Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer
Author:
Affiliation:
1. Fundación Ciencia & Vida; Santiago Chile
2. Medivation, Inc.; San Francisco California
Publisher
Wiley
Subject
Urology,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.22674/fullpdf
Reference65 articles.
1. Treating prostate cancer in elderly men: How does aging affect the outcome;Shelke;Curr Treat Options Oncol,2011
2. Molecular mechanisms of castration-resistant prostate cancer progression;Dutt;Future Oncol,2009
3. Androgen regulation of gene expression;Lamont;Adv Cancer Res,2010
4. The role of the androgen receptor in the development and progression of prostate cancer;Jenster;Semin Oncol,1999
5. Progression of prostate cancer: Multiple pathways to androgen independence;Devlin;Cancer Lett,2009
Cited by 91 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor;Bioorganic Chemistry;2024-02
2. Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy;Toxicology and Applied Pharmacology;2023-11
3. Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling;Cancer Research;2023-09-07
4. A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer;Molecular Cancer Therapeutics;2023-07-24
5. Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells;Stem Cell Reports;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3